Related references
Note: Only part of the references are listed.Safety, efficacy, and biomarker findings of PBT2 in targeting Aβ as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial (vol 7, pg 779, 2008)
L. Lannfelt et al.
LANCET NEUROLOGY (2009)
Semi-quantitative analysis of α-synuclein in subcellular pools of rat brain neurons: An immunogold electron microscopic study using a C-terminal specific monoclonal antibody
Ling Zhang et al.
BRAIN RESEARCH (2008)
Assembly-dependent endocytosis and clearance of extracellular alpha-synuclein
He-Jin Lee et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2008)
Site-specific interactions of Cu(II) with α and β-synuclein:: Bridging the molecular gap between metal binding and aggregation
Andres Binolfi et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2008)
Rapid restoration of cognition in Alzheimer's transgenic mice with 8-hydroxy quinoline analogs is associated with decreased interstitial Aβ
Paul A. Adlard et al.
NEURON (2008)
Formation of Toxic Oligomeric α-Synuclein Species in Living Cells
Tiago Fleming Outeiro et al.
PLOS ONE (2008)
Safety, efficacy, and biomarker findings of PBT2 in targeting Aβ as a modifying therapy for Alzheimer's disease:: a phase IIa, double-blind, randomised, placebo-controlled trial
Lars Lannfelt et al.
LANCET NEUROLOGY (2008)
Origins and effects of extracellular alpha-synuclein: Implications in Parkinson's disease
Seung-Jae Lee
JOURNAL OF MOLECULAR NEUROSCIENCE (2008)
Different species of α-synuclein oligomers induce calcium influx and seeding
Karin M. Danzer et al.
JOURNAL OF NEUROSCIENCE (2007)
Thermodynamics imprinting reveals differential binding of metals to α-synuclein:: Relevance to parkinson's disease
Bharathi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
The impact of the E46K mutation on the properties of α-synuclein in its monomeric and oligomeric states
Ross A. Fredenburg et al.
BIOCHEMISTRY (2007)
Quantitative morphological analysis reveals ultrastructural diversity of amyloid fibrils from α-synuclein mutants
Martijn E. van Raaij et al.
BIOPHYSICAL JOURNAL (2006)
Decreased α-synuclein in cerebrospinal fluid of aged individuals and subjects with Parkinson's disease
Takahiko Tokuda et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
The plasma alpha-synuclein levels in patients with Parkinson's disease and multiple system atrophy
P. H. Lee et al.
JOURNAL OF NEURAL TRANSMISSION (2006)
Interaction of α-synuclein with divalent metal ions reveals key differences:: A link between structure, binding specificity and fibrillation enhancement
Andres Binolfi et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2006)
Excess of nonceruloplasmin serum copper in AD correlates with MMSE, CSF β-amyloid, and h-tau
R. Squitti et al.
NEUROLOGY (2006)
Plasma membrane ion permeability induced by mutant α-synuclein contributes to the degeneration of neural cells
K Furukawa et al.
JOURNAL OF NEUROCHEMISTRY (2006)
Down-regulation of α-synuclein expression can rescue dopaminergic cells from cell death in the substantia nigra of Parkinson's disease rat model
H Hayashita-Kinoh et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Detection of oligomeric forms of α-synuclein protein in human plasma as a potential biomarker for Parkinson's disease
Omar M. A. El-Agnaf et al.
FASEB JOURNAL (2006)
Characterization of oligomers during α-synuclein aggregation using intrinsic tryptophan fluorescence
A Dusa et al.
BIOCHEMISTRY (2006)
Parkinson's disease α-synuclein transgenic mice develop neuronal mitochondrial degeneration and cell death
LJ Martin et al.
JOURNAL OF NEUROSCIENCE (2006)
Neural activity controls the synaptic accumulation of α-synuclein
DL Fortin et al.
JOURNAL OF NEUROSCIENCE (2005)
α-synuclein cooperates with CSPα in preventing neurodegeneration
S Chandra et al.
CELL (2005)
Molecular-level secondary structure, polymorphism, and dynamics of full-length α-synuclein fibrils studied by solid-state NMR
H Heise et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Proteolytic cleavage of extracellular secreted α-synuclein via matrix metalloproteinases
JY Sung et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Forcing nonamyloidogenic β-synuclein to fibrillate
G Yamin et al.
BIOCHEMISTRY (2005)
Intravesicular localization and exocytosis of α-synuclein and its aggregates
HJ Lee et al.
JOURNAL OF NEUROSCIENCE (2005)
Structural characterization of copper(II) binding to α-synuclein:: Insights into the bioinorganic chemistry of Parkinson's disease
RM Rasia et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Phthalocyanine tetrasulfonates affect the amyloid formation and cytotoxicity of α-synuclein
EN Lee et al.
BIOCHEMISTRY (2004)
The new mutation, E46K, of α-synuclein causes Parkinson and Lewy body dementia
JJ Zarranz et al.
ANNALS OF NEUROLOGY (2004)
β-Synuclein gene alterations in dementia with Lewy bodies
H Ohtake et al.
NEUROLOGY (2004)
Protective effect of TAT-delivered α-synuclein:: relevance of the C-terminal domain and involvement of HSP70
D Albani et al.
FASEB JOURNAL (2004)
α-synuclein implicated in Parkinson's disease is present in extracellular biological fluids, including human plasma
OMA El-Agnaf et al.
FASEB JOURNAL (2003)
A peptide motif consisting of glycine, alanine, and valine is required for the fibrillization and cytotoxicity of human α-synuclein
HN Du et al.
BIOCHEMISTRY (2003)
Lipid interaction of α-synuclein during the metal-catalyzed oxidation in the presence of Cu2+ and H2O2
EN Lee et al.
JOURNAL OF NEUROCHEMISTRY (2003)
Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting A beta amyloid deposition and toxicity in Alzheimer disease - A pilot phase 2 clinical trial
CW Ritchie et al.
ARCHIVES OF NEUROLOGY (2003)
α-Synuclein regulates neuronal survival via Bcl-2 family expression and PI3/Akt kinase pathway
JH Seo et al.
FASEB JOURNAL (2002)
α-synuclein, especially the Parkinson's disease-associated mutants, forms pore-like annular and tubular protofibrils
HA Lashuel et al.
JOURNAL OF MOLECULAR BIOLOGY (2002)
Dependence of α-synuclein aggregate morphology on solution conditions
W Hoyer et al.
JOURNAL OF MOLECULAR BIOLOGY (2002)
Annular α-synuclein protofibrils are produced when spherical protofibrils are incubated in solution or bound to brain-derived membranes
TT Ding et al.
BIOCHEMISTRY (2002)
α-Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's disease
C Lo Bianco et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Neurodegenerative disease - Amyloid pores from pathogenic mutations
HA Lashuel et al.
NATURE (2002)
Human α-synuclein-harboring familial Parkinson's disease-linked Ala-53→Thr mutation causes neurodegenerative disease with α-synuclein aggregation in transgenic mice
MK Lee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Magnesium inhibits spontaneous and iron-induced aggregation of α-synuclein
N Golts et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Vesicle permeabilization by protofibrillar α-synuclein is sensitive to Parkinson's disease-linked mutations and occurs by a pore-like mechanism
MJ Volles et al.
BIOCHEMISTRY (2002)
Metal-triggered structural transformations, aggregation, and fibrillation of human α-synuclein -: A possible molecular link between Parkinson's disease and heavy metal exposure
VN Uversky et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Effect of familial Parkinson's disease point mutations A30P and A53T on the structural properties, aggregation, and fibrillation of human α-synuclein
J Li et al.
BIOCHEMISTRY (2001)
Induction of neuronal cell death by Rab5A-dependent endocytosis of α-synuclein
JY Sung et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Vesicle permeabilization by protofibrillar α-synuclein:: Implications for the pathogenesis and treatment of Parkinson's disease
MJ Volles et al.
BIOCHEMISTRY (2001)
Conformational properties of α-synuclein in its free and lipid-associated states
D Eliezer et al.
JOURNAL OF MOLECULAR BIOLOGY (2001)
A hydrophobic stretch of 12 amino acid residues in the middle of α-synuclein is essential for filament assembly
BI Giasson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Parkinson's disease-associated α-sylnuclein is more fibrillogenic than β- and γ-synuclein and cannot cross-seed its homologs
AL Biere et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Full length α-synuclein is present in cerebrospinal fluid from Parkinson's disease and normal subjects
R Borghi et al.
NEUROSCIENCE LETTERS (2000)
Fresh and nonfibrillar amyloid β protein(1-40) induces rapid cellular degeneration in aged human fibroblasts:: evidence for AβP-channel-mediated cellular toxicity
YJ Zhu et al.
FASEB JOURNAL (2000)
Fresh and globular amyloid β protein (1-42) induces rapid cellular degeneration:: evidence for AβP channel-mediated cellular toxicity
R Bhatia et al.
FASEB JOURNAL (2000)
Review:: Formation and properties of amyloid-like fibrils derived from α-synuclein and related proteins
OMA El-Agnaf et al.
JOURNAL OF STRUCTURAL BIOLOGY (2000)
Chaperone-like activity of synucleins
JM Souza et al.
FEBS LETTERS (2000)
Alzheimer's β-amyloid, human islet amylin, and prion protein fragment evoke intracellular free calcium elevations by a common mechanism in a hypothalamic GnRH neuronal cell line
M Kawahara et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Toxicity of non-Aβ component of Alzheimer's disease amyloid, and N-terminal fragments thereof, correlates to formation of β-sheet structure and fibrils
AM Bodles et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2000)
Membrane association and protein conformation of α-synuclein in intact neurons -: Effect of Parkinson's disease-linked mutations
PJ McLean et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Dopaminergic loss and inclusion body formation in α-synuclein mice:: Implications for neurodegenerative disorders
E Masliah et al.
SCIENCE (2000)
Acceleration of oligomerization, not fibrillization, is a shared property of both α-synuclein mutations linked to early-onset Parkinson's disease:: Implications for pathogenesis and therapy
KA Conway et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system
A Abeliovich et al.
NEURON (2000)
Share Paper
